Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study.
Journal: Infectious diseases and therapy
Published: December 18, 2023
Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis.
Journal: Open forum infectious diseases
Published: July 27, 2023
Exploring Social Networking Technologies as Tools for HIV Prevention for Men Who Have Sex With Men.
Journal: AIDS education and prevention : official publication of the International Society for AIDS Education
Published: August 05, 2015
Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial.
Journal: JAMA
Published: February 24, 2015
Safety and efficacy of ombitasvir - 450/r and dasabuvir and ribavirin in HCV/HIV-1 co-infected patients receiving atazanavir or raltegravir ART regimens.
Journal: Journal of the International AIDS Society
Published: November 14, 2014
Dolutegravir versus placebo in subjects harbouring HIV-1 with integrase inhibitor resistance associated substitutions: 48-week results from VIKING-4, a randomized study.
Journal: Antiviral therapy
Published: September 29, 2014
Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
Journal: Postgraduate medicine
Published: July 03, 2013
Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Journal: Postgraduate medicine
Published: July 03, 2013
12-month observation of testosterone replacement effectiveness in a general population of men.
Journal: Postgraduate medicine
Published: July 03, 2013
Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS).
Journal: Clinical interventions in aging
Published: August 22, 2012
Patient monitoring and follow-up in lentiviral clinical trials.
Journal: The journal of gene medicine
Published: July 26, 2012
Injectable poly-L-lactic acid for human immunodeficiency virus-associated facial lipoatrophy: cumulative year 2 interim analysis of an open-label study (FACES).
Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
Published: July 05, 2012
Last Updated: 09/26/2026